The Linx Reflux Management System is a small band of magnetic beads wrapped around the esophagus that treats GERD.
Here’s what you should know:
1. Researchers conducted a study with 152 patients, which was published in Gastrointestinal Endoscopy. About 102 received twice-daily proton pump inhibitors and 50 received laparoscopic magnetic sphincter augmentation with the Linx system.
2. Eighty-nine percent of the Linx cohort achieved relief from moderate to severe regurgitation, compared to only 10 percent of the PPI cohort.
3. Eighty-one percent of the Linx cohort reported improvement of 50 percent or more in GERD quality scores, compared to 8 percent of the PPI cohort.
4. Ninety-one percent of the Linx cohort experienced a normal amount of reflux episodes at six months, compared to 58 percent of the PPI cohort.
5. The Linx cohort also had a greater patient satisfaction (81 percent) than the PPI cohort (2 percent).
Study co-author Reginald C. W. Bell, MD, said in a press release, “This study demonstrated that patients experiencing regurgitation despite proton-pump inhibitor therapy actually did extremely well with an anti-reflux procedure, magnetic sphincter augmentation, using the Linx device.”
More articles on gastroenterology:
The Leapfrog Group expands ratings to include ASCs, will survey 5K+
KKR completes Envision (AmSurg) acquisition & more — 6 ASC company key notes
5 challenges ASCs face when providing effective infection control training
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
